eli lilly is selling zepbound directly to consumers via its LillyDirect platform, offering significant discounts but requiring out-of-pocket payments as most health insurers do not cover the drug, exacerbating affordability issues for many potential users.

An obesity drug that consumers can buy directly from eli lilly.

The drugmaker selling zepbound directly through its LillyDirect platform.

CEO of eli lilly discussing the accessibility of zepbound.

Company that reported on the loss of health insurance coverage for zepbound.

Organization that reported on obesity statistics in American adults.